However, the literature suggests that although low correlations between practitioners' determination of disease presence, severity and treatment of individuals remains problematic in predicting treatment plans, such correlations may be useful in predicting resource supply or formulating broad public health policy decisions [ 13, 32].
Selection of an appropriate control has been problematic in light treatment research, since, as in the case of some other medical devices, the modality of treatment cannot be "blind".
Yes, it is "problematic" in its treatment of gender, race and sexuality.
Chronic spine-related conditions are very problematic in terms of treatment and indemnity costs, diagnostic complexity, and appropriate case management.
Moreover, side-effects of monotherapy with Acetylsalicylic acid has been suggested to be more problematic in this setting, and treatment with Acetylsalicylic presuppose adequate blood pressure control [ 45].
However, evaluating the national programme is problematic because of changes over time in treatment and in the underlying incidence of disease (Prior et al, 1996; Blanks et al, 2000a).
Based on the experiences of the participants in this study, venesection was an acceptable first choice in treatment; however, some problematic aspects were introduced and, as low-dose chloroquine is widely used, 4 this might be preferable for some patients.
While specific modalities are effective to a degree, the aggregate spine disease treatment remains problematic in that there are few clear technological solutions that can completely alleviate chronic back pain, especially when due to advanced disc degeneration.
Follow-up was less problematic in studies providing opiate substitution treatment.
Unfortunately, adherence and persistence with treatment are problematic in all chronic diseases and pose particular challenges in osteoporosis.
